Size distribution analysis of recombinant adenovirus using disc centrifugation
Author(s) -
LL Bondoc,
Stephen Fitzpatrick
Publication year - 1998
Publication title -
journal of industrial microbiology and biotechnology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 112
eISSN - 1476-5535
pISSN - 1367-5435
DOI - 10.1038/sj.jim.2900529
Subject(s) - recombinant dna , centrifuge , centrifugation , virus , virology , adenoviridae , viral vector , recombinant virus , distribution (mathematics) , microbiology and biotechnology , virus quantification , biology , chemistry , chromatography , physics , gene , biochemistry , mathematics , mathematical analysis , nuclear physics
Recombinant adenovirus is one of the primary vectors for human gene therapy. However, the aggregation of unstable virus has been a recurring problem during the production of purified virus for human therapeutics. To facilitate the development of a robust manufacturing process for recombinant adenovirus vectors, a convenient and reliable size distribution analytical assay is necessary and we demonstrate here that disc centrifuge sedimentation is applicable to this purpose. Using the disc centrifuge system and the line start method, the assay can provide particle size distribution of adenovirus samples within 30 min. The assay can detect virus concentrations down to 0.01% (w/v) or 3 × 1011 particles per ml. The apparent hydrodynamic diameter of recombinant adenovirus was determined to be about 0.063 μm. Furthermore, the disc centrifuge analysis was able to detect adenovirus dimers, trimers, and tetramers, consistent with a rigid sphere approximation for adenovirus, as well as a large aggregate of 0.35 μm. The appearance of viral aggregates is confirmed by increased light scattering based on A320/A260 ratios. The technique could be useful for monitoring the kinetics of aggregation for adenovirus and other DNA and RNA viruses in the submicron region. Therefore, this novel assay provides a critical tool for purification development of viral vectors for meeting therapeutic and research needs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom